美国食品药品监督管理局敦促制造商寻求批准治疗男性低性欲, FDA urges manufacturers to seek approval for treating low libido in men with unexplained low testosterone.

美国食品和药物管理局正在鼓励制造商寻求批准治疗男性的低性欲, The U.S. FDA is encouraging manufacturers to seek approval for treating low libido in men with unexplained low testosterone, known as idiopathic hypogonadism. 目前, 治疗仅被批准用于有特定病因的男性. Currently, testosterone therapy is only approved for men with specific medical causes. 该机构要求公司在等待安全性和有效性的审查之前, 于4月30日前提交数据. The agency has asked companies to submit data by April 30, pending a safety and effectiveness review.